News Reader
12-18-2008, 11:51 AM
The U.S. Food and Drug Administration recommended today that manufacturers developing new drugs and biologics for type 2 diabetes provide evidence that the therapy will not increase the risk of such cardiovascular events as a heart attack. The recommendation is part of a new guidance for industry that applies to all diabetes drugs currently under development.
More... (http://www.fda.gov/bbs/topics/NEWS/2008/NEW01928.html)
More... (http://www.fda.gov/bbs/topics/NEWS/2008/NEW01928.html)